Results 61 to 70 of about 1,156,033 (197)
Alimentary Pharmacology &Therapeutics, EarlyView.Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala +13 more
wiley +1 more source
Circulatory function and hepatorenal syndrome in cirrhosis
, 2005 The pathogenic mechanism of hepatorenal syndrome is not well established. We investigated the circulatory function in cirrhosis before and after the development of hepatorenal syndrome.
Monescillo Francia, Alberto Fernando +8 more
core +1 more source
Hepatology Research, EarlyView.ABSTRACT Aim The therapeutic significance of recombinant a disintegrin‐like and metalloprotease with thrombospondin type 1 motif 13 (rADAMTS13) in acute‐on‐chronic liver failure (ACLF) remains unclear. We aimed to investigate the therapeutic effects of rADAMTS13 in a murine model of ACLF‐like liver injury.
Jun‐ichi Hanatani +9 more
wiley +1 more source
CLINICAL EFFICACY OF ALBUMIN DIALYSIS THERAPY FOR PATIENTS WITH HEPATORENAL SYNDROME
Вестник трансплантологии и искусственных органов, 2009 34 patients (23 male, 11 female) in the age of 41–77 years (mean age 59,7 ± 4,2 years) with 2 type hepatorenal syndrome were included in the study. All patients were divided in 3 groups.
D. E. Kutepov +8 more
doaj +1 more source
Journal of Gastroenterology and Hepatology, EarlyView.ABSTRACT Background and Aim Alcohol‐associated liver disease frequently presents late as decompensated cirrhosis, representing a missed opportunity for intervention. Extrahepatic alcohol‐related presentations requiring acute care, such as alcohol‐associated pancreatitis and alcohol withdrawal syndrome, may identify heavy drinkers at varying risk for ...
Butros Fakhoury +5 more
wiley +1 more source
Type 1 Hepatorenal Syndrome [PDF]
, 2016 Type 1 hepatorenal syndrome is kidney failure that occurs in advanced cirrhosis (Fagundes & Ginès, 2012). It is characterized by a, “significant reduction in creatinine clearance within 1-2 weeks of presentation” (Bacon, 2015). Patients that develop this
Evans, Ernest
core
Role of human albumin in the management of liver cirrhosis
Медицинский совет, 2020 Aim. To demonstrate the role of concentrated human albumin in cirrhotic patient management.The main content. Albumin has a clear place in the clinical practice of cirrhotic patients managing.
M. V. Maevskaya, M. S. Zharkova
doaj +1 more source
Journal of Gastroenterology and Hepatology, EarlyView.ABSTRACT Background Pharmacologic therapies to prevent decompensation in cirrhosis remain limited. Aim To evaluate the association between aspirin use and cirrhosis‐related outcomes and mortality. Methods This retrospective cohort study utilized deidentified electronic health records from a global federated network (January 2013–July 2025). Adults with
Shahem Abbarh +6 more
wiley +1 more source
Terlipressin for hepatorenal syndrome
, 2012 Clinical trials suggest that terlipressin improves renal function in hepatorenal syndrome, but the evidence concerning mortality is ...
Kurt Christensen +7 more
core +1 more source
Intrarenal Resistance Index as a Prognostic Parameter in Patients with Liver Cirrhosis Compared with Other Hepatic Scoring Systems [PDF]
, 2012 Background and Aims: Patients with advanced liver cirrhosis who develop renal dysfunction have a poor prognosis. Elevated intrarenal resistance indices (RIs) due to renal vascular constriction have been described before in cirrhotic patients.
Kaiser, C. +7 more
core +1 more source